108 related articles for article (PubMed ID: 158055)
1. In vivo elimination by specific effector cells of an established syngeneic rat moloney virus-induced sarcoma.
Fernandez-Cruz E; Halliburton B; Feldman JD
J Immunol; 1979 Oct; 123(4):1772-7. PubMed ID: 158055
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy of a chemically-induced sarcoma in rats: characterization of the effector T cell subset and nature of suppression.
Fernandez-Cruz E; Gilman SC; Feldman JD
J Immunol; 1982 Mar; 128(3):1112-7. PubMed ID: 6460058
[TBL] [Abstract][Full Text] [Related]
3. Generation of cytotoxic lymphocytes in vitro: response of immune rat spleen cells to a syngeneic gross virus-induced lymphoma in mixed lymphocyte-tumor culture.
Bernstein ID; Wright PW; Cohen E
J Immunol; 1976 May; 116(5):1367-72. PubMed ID: 58029
[TBL] [Abstract][Full Text] [Related]
4. Effect of macrophages and antibodies on in vivo growth of Moloney sarcoma in the rat.
Miller GA; Feldman JD
J Immunol; 1977 Oct; 119(4):1445-51. PubMed ID: 302284
[TBL] [Abstract][Full Text] [Related]
5. Passive transfer of systemic tumor immunity with cells generated in vitro by a secondary immune response to a syngeneic rat gross virus-induced lymphoma.
Bernstein ID
J Immunol; 1977 Jan; 118(1):122-8. PubMed ID: 830744
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated antigens of rat moloney sarcoma cells. I. Cell-surface antigens.
Leung K; Jones JM; Feldman JD
J Immunol; 1978 Nov; 121(5):1836-43. PubMed ID: 81854
[TBL] [Abstract][Full Text] [Related]
7. Tumor-associated antigens of rat moloney sarcoma cells. II. Cytosol antigens.
Leung K; Feldman JD
J Immunol; 1978 Nov; 121(5):1844-8. PubMed ID: 309482
[TBL] [Abstract][Full Text] [Related]
8. Increased sensitivity of murine leukemia virus-infected tumor cells to lymphocyte-mediated cytotoxicity.
Kasai M; Yamaguchi H; Hosokawa M; Mizushima Y; Kobayashi H
J Natl Cancer Inst; 1981 Aug; 67(2):417-22. PubMed ID: 6267345
[TBL] [Abstract][Full Text] [Related]
9. Sequential quantitation of circulating immune complexes in syngeneic and allogeneic rats bearing Moloney sarcomas.
Jennette JC; Feldman JD
J Immunol; 1977 Jun; 118(6):2269-74. PubMed ID: 301157
[TBL] [Abstract][Full Text] [Related]
10. Role of accessory cells in the induction of a secondary cytotoxic response to Moloney murine sarcoma virus-induced tumors.
Biasi G; Saggin L; Dazzi F; De Rossi A; Collavo D
J Immunol; 1983 Mar; 130(3):1447-50. PubMed ID: 6185589
[TBL] [Abstract][Full Text] [Related]
11. In vitro reeducated T helper cells from sarcoma-bearing mice inhibit sarcoma growth in vivo.
Forni G; Giovarelli M
J Immunol; 1984 Jan; 132(1):527-33. PubMed ID: 6228583
[TBL] [Abstract][Full Text] [Related]
12. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
Ng AK; Ames RS; McIntire RK; Herberman RB
Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
[TBL] [Abstract][Full Text] [Related]
13. Characterization of immunosuppressor cells in rats immunized with solubilized tumor-associated antigens prepared from a methylcholanthrene-induced fibrosarcoma.
Minami A; Kasai M; Mizushima Y; Takeichi N; Hosokawa M; Kobayashi H
Cancer Res; 1980 Jul; 40(7):2129-34. PubMed ID: 6446378
[TBL] [Abstract][Full Text] [Related]
14. Effect of Nocardia rubra cell wall skeleton on T-cell-mediated cytotoxicity in mice bearing syngeneic sarcoma.
Kawase I; Uemiya M; Yoshimoto T; Ogura T; Hirao F; Yamamura Y
Cancer Res; 1981 Feb; 41(2):660-6. PubMed ID: 6969630
[TBL] [Abstract][Full Text] [Related]
15. p30-Anti-p30 immune complexes: intravascular clearance and extravascular sequestration in rats bearing Moloney sarcoma.
Jennette JC; Feldman JD
J Immunol; 1978 Nov; 121(5):1696-700. PubMed ID: 712062
[TBL] [Abstract][Full Text] [Related]
16. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
Vallera DA; Mentzer SJ; Maizel SE
Cancer Res; 1982 Feb; 42(2):397-404. PubMed ID: 7055792
[TBL] [Abstract][Full Text] [Related]
17. Requirements for T cells in alloantigen-induced generation of non-T cell-mediated cytotoxicity against syngeneic mouse sarcoma cells.
Paciucci PA; Macphail S; Bach FH; Zarling JM
J Immunol; 1980 Jul; 125(1):36-9. PubMed ID: 6155401
[TBL] [Abstract][Full Text] [Related]
18. Specific induction of local antitumor effector cells mediated in vivo by the circulating lymphocyte pool.
Crum ED
Cancer Res; 1987 Nov; 47(21):5584-9. PubMed ID: 3311355
[TBL] [Abstract][Full Text] [Related]
19. Adoptive immunotherapy of a newly induced sarcoma: immunologic characteristics of effector cells.
Shu S; Rosenberg SA
J Immunol; 1985 Oct; 135(4):2895-903. PubMed ID: 2411817
[TBL] [Abstract][Full Text] [Related]
20. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
[No Abstract] [Full Text] [Related]
[Next] [New Search]
